Based on recent data, Ovid Therapeutics Inc. (OVID) shows an Average True Range (ATR) of 0.12 and an Enterprise Value of 241.7M. Its average trading volume over the past 3 months is 1.62M, indicating liquidity. These fundamental metrics provide insight into OVID's underlying financial health and market activity.
| ATR | 0.12 |
| Enterprise Value | 241.7M |
| Avg Vol (3 Months) | 1.62M |
| Avg Vol (10 Days) | 1.8M |
Ovid Therapeutics Inc. (OVID) technical indicators as of February 7, 2026: the SMA 20 is -0.44%, SMA 50 at -1.84%, and SMA 200 at 52.92%. The RSI 14 value is 49.97, suggesting its current momentum. These technical analysis signals help assess OVID's price trends and potential future movements.
| SMA 20 | -0.44% |
| SMA 50 | -1.84% |
| SMA 200 | 52.92% |
| RSI 14 | 49.97 |
Ovid Therapeutics Inc. (OVID) stock performance overview as of February 7, 2026: The 52-week high is $2.01 (currently -20.4% below), and the 52-week low is $0.243 (currently 559.79% above). Over the past year, OVID's performance is 108.22%, compared to the S&P 500's 8.57% change.
| 52-Week High | 2.01 |
| 52-Week High Chg | -20.40% |
| 52-Week Low | 0.2425 |
| 52-Week Low Chg | +559.79% |
| S&P 500 52-Week Chg | 8.57% |
According to market data, Ovid Therapeutics Inc. (OVID) stock's recent performance metrics show that over the last month, OVID is 2.7%, with a Year-to-Date (YTD) performance of -6.75%. Over the past year, the stock has seen a 108.22% change. These figures summarize OVID's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 1.61 | 1.87 | 1.88 | 2.01 | 2.01 | 1.87 |
| Low | 1.4 | 1.4 | 1.18 | 0.5 | 0.2425 | 1.4 |
| Performance | -5.59% | +2.70% | +2.70% | +151.07% | +108.22% | -6.75% |
According to current financial data, OVID stock's P/E (TTM) ratio is -3.06, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for OVID, including P/S (16.86), P/B (2.49), and P/FCF (-2.94), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | OVID | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -3.06 | -1.23 | -5.15 | 32.59 |
| P/S (TTM) | 16.86 | 3.71 | 464.72 | 5.98 |
| P/B (TTM) | 2.49 | 0.13 | 9.08 | 5.47 |
| P/FCF (TTM) | -2.94 | -6.89 | -200.6 | 32.07 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep